AOD-9604 vs Semaglutide.
Quick Verdict
AOD-9604 is a gh fragment primarily researched for fat loss without gh side effects, while Semaglutide is a glp-1 agonist studied for fat loss, appetite control, cardiovascular benefits. A key distinction: Semaglutide has FDA approval status.
Side-by-Side Analysis
| Dimension | AOD-9604 | Semaglutide |
|---|---|---|
| Category | GH Fragment | GLP-1 Agonist |
| Mechanism | Mimics GH fat-burning domain. | GLP-1 receptor agonism mimics the incretin hormone to reduce appetite, slow gastric emptying, improve insulin sensitivity, and provide cardiovascular protection. |
| Half-Life | ~1 hours | ~7 days |
| Route | SubQ | SubQ |
| Typical Dose | 300–300 mcg | 250–250 mcg |
| Frequency | 7x/wk | 1x/wk |
| Evidence Level | Preclinical | Very Strong |
| Indexed Studies | 18+ indexed | 20+ indexed |
| FDA Status | Research Only | Approved |
| Lowest Price | $49.99 / 5mg via Amino Club | $47.99 / 5mg via Amino Club |
| Per-mg Cost | $10.00/mg | $9.60/mg |
Mechanism of Action Comparison
How AOD-9604 Works
AOD-9604 AOD-9604 is a synthetic fragment of human growth hormone studied for its ability to burn fat without the blood sugar or growth side effects of full GH.
Mimics GH fat-burning domain. Stimulates lipolysis and inhibits lipogenesis by acting on beta-3 adrenergic receptors in fat tissue, without binding to the GH receptor.
How Semaglutide Works
Semaglutide Semaglutide is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes (Ozempic) and obesity (Wegovy), reducing appetite and improving blood sugar control.
GLP-1 receptor agonism mimics the incretin hormone to reduce appetite, slow gastric emptying, improve insulin sensitivity, and provide cardiovascular protection.
Key Mechanistic Difference
AOD-9604 operates as a gh fragment, while Semaglutide functions as a glp-1 agonist — these are fundamentally different pharmacological approaches. Semaglutide has a significantly longer half-life (~7 days) compared to AOD-9604 (~1 hours), which impacts dosing frequency and sustained activity.
Research Evidence
AOD-9604
18 studies- AOD-9604 lipolysis stimulation in preclinical modelsNg et al. demonstrate AOD-9604 stimulates lipolysis and inhibits lipogenesis in adipose tissue without affecting IGF-1 o…Preclinical
- AOD-9604 clinical safety six randomized controlled trialsHeffernan et al.: Pooled analysis of 6 RCTs showing AOD-9604 is well-tolerated with a safety profile similar to placebo …Moderate
- AOD-9604 Phase IIb trial short-term fat reduction12-week Phase IIb trial: 1mg/day AOD-9604 produced 2.6 kg weight loss vs 0.8 kg placebo, with reductions in abdominal fa…Moderate
Semaglutide
20 studies- STEP 1: Semaglutide 2.4 mg for weight managementWilding et al. (NEJM): Landmark STEP 1 trial semaglutide 2.4mg achieved 14.9% mean weight loss vs 2.4% placebo at 68 w…Very Strong
- SELECT trial: semaglutide reduces cardiovascular events by 20%Lincoff et al. (NEJM): SELECT trial shows semaglutide 2.4mg reduces major adverse cardiovascular events by 20% in overwe…Very Strong
- STEP program overview: pooled Phase 3 weight loss dataComprehensive analysis across STEP trials showing 14.9-17.4% weight loss, improved cardiometabolic risk factors, blood p…Very Strong
Vendor Pricing
· Affiliate links · Prices verified 2026AOD-9604
2 vendorsSemaglutide
2 vendorsAffiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.
Frequently Asked Questions
Can I take AOD-9604 and Semaglutide together?▼
Yes — AOD-9604 and Semaglutide are identified as synergistic in interaction databases. They operate through complementary mechanisms and are commonly combined in research protocols.
Which has more research evidence — AOD-9604 or Semaglutide?▼
AOD-9604 has 18 indexed studies (highest evidence: Preclinical). Semaglutide has 20 indexed studies (highest evidence: Very Strong). Semaglutide has a more extensive research base.
What is the price difference between AOD-9604 and Semaglutide?▼
At current verified vendor prices, Semaglutide starts at $9.60/mg while AOD-9604 starts at $10.00/mg. Prices vary by vendor and vial size — see the full vendor comparison below.
Which is better for fat loss — AOD-9604 or Semaglutide?▼
Both are researched for fat loss. AOD-9604 addresses this via fat loss without gh side effects. Semaglutide approaches it through fat loss, appetite control, cardiovascular benefits. The optimal choice depends on your specific research protocol and which mechanism aligns with your objectives.
Is AOD-9604 or Semaglutide FDA-approved?▼
Semaglutide has FDA approval (or is derived from an FDA-approved compound). AOD-9604 is a research compound without FDA approval for human use. FDA status reflects regulatory evaluation — not necessarily superiority for all research applications.
Related Comparisons
Deep Dive Profiles
Shared Research Goals
Research Use Only — Not Medical Advice
This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.